Published in
Elsevier, The Lancet, 10044(388), p. 565-575, 2016
DOI: 10.1016/s0140-6736(16)00739-x
Links
Tools
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
Journal article published in 2016 by
Olivier Hermine 
,
Eva Hoster,
Jan Walewski ,
André Bosly,
Stephan Stilgenbauer,
Catherine Thieblemont,
Michal Szymczyk,
Reda Bouabdallah,
Michael Kneba,
Michael Hallek,
Gilles Salles,
Pierre Feugier,
Vincent Ribrag,
Josef Birkmann,
Roswitha Forstpointner
and other authors.
,
Eva Hoster,
Jan Walewski ,
André Bosly,
Stephan Stilgenbauer,
Catherine Thieblemont,
Michal Szymczyk,
Reda Bouabdallah,
Michael Kneba,
Michael Hallek,
Gilles Salles,
Pierre Feugier,
Vincent Ribrag,
Josef Birkmann,
Roswitha Forstpointner
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
International audience